Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Nobuyuki, Sekine"'
Publikováno v:
Expert Opinion on Drug Safety. 21:691-698
This study evaluated the safety and effectiveness of ramucirumab and docetaxel for non-small cell lung cancer (NSCLC) in real-world settings.This single-arm, prospective, multicenter, non-interventional, post-marketing study was conducted in Japan be
Autor:
Makoto, Nishio, Yuichiro, Ohe, Kadoaki, Ohashi, Ryo, Toyozawa, Miyako, Satouchi, Nobuyuki, Sekine, Joji, Mori, Sotaro, Enatsu, Koichi, Goto
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 49(6)
Selpercatinib is a highly selective, potent, rearranged during transfection(RET)inhibitor. A global, multicenter, open-label, phase 1/2 study of selpercatinib(LIBRETTO-001, NCT03157128)has been ongoing since 2017. We evaluated the data of Japanese pa
Publikováno v:
Therapeutic Innovation & Regulatory Science. 50:472-479
In 2012, the US Food and Drug Administration (FDA) issued the draft guidance “Determining the Extent of Safety Data Collection Needed in Late Stage Premarket and Postapproval Clinical Investigations.” The selective data collection approach propos
Publikováno v:
Chemistry Letters. 44:659-661
We showed that a thermally stable europium complex can be used as a fluorescence probe to characterize glass-transition behavior for polymers. This kind of simple but novel work opens many possibil...
Publikováno v:
Organic Electronics. 10:1473-1477
We report a unique nano-ridge structure of zinc oxide (ZnO) and its application in high performance inverted polymer solar cells. The ZnO nano-ridge structure was formed by a sol– gel process using a ramp annealing method. As the solvent slowly eva
Publikováno v:
Molecular Crystals and Liquid Crystals Science and Technology. Section A. Molecular Crystals and Liquid Crystals. 306:75-80
Title compound, a cross-conjugated biradical with phenoxylnitronyl nitroxide structure, was prepared by the lead dioxide oxidation of a p-hydroxyphenyl nitronyl nitroxide, 2-(3,5-di-tert-butyl-4-hydroxyphenyl)-4,4,5,5-tetramethyl-4,5,-dihydro-1H-imid
Publikováno v:
Molecular and Cellular Biochemistry. 138:135-140
The exoenzyme C3 produced by Clostridium botulinum catalyzes ADP-ribosylation of rho gene products which belong to a family of small molecular-weight GTP-binding proteins. The C3 enzyme-catalyzed ADP-ribosylation of rho proteins partially purified fr
Publikováno v:
AMC
In this research, Authors participated in a research project about “Development of Intelligent Power Wheelchair assisting for people on Daily Life”. Recently, the number of elderly people increases. And the development of welfare apparatus having
[Role of pharmaceutical company pharmacist in provision of drug information for cancer chemotherapy]
Autor:
Iori, Koshida, Kenichi, Kubota, Masaki, Yamashita, Hideya, Katayanagi, Kohei, Noda, Hakaru, Terada, Shinichi, Yoshioka, Nobuyuki, Sekine, Toshikazu, Kameda, Kiyoshi, Terada
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 36(4)
Recently, oxaliplatin(L-OHP)and irinotecan hydrochloride hydrate(CPT-11)have gained recognition as key drugs in the treatment of advanced colorectal cancer. In this article, we describe the results of a survey of medical institutions by pharmacists w
Autor:
Nobuyuki, Sekine, Kiyoshi, Terada
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 33(11)
CPT-11 (irinotecan hydrochloride, trade name: Campto or Topotecin) was launched in 1994. L-OHP (oxaliplatin, trade name: Elplat) was approved based on the fast track evaluation system and launched in 2005. Originally, both of these drugs were synthes